C84.04

Clinical Causes: The exact cause of mycosis fungoides remains unknown. It involves malignant T-lymphocytes (a type of immune cell) that become cancerous and grow abnormally. Genetic mutations within these lymphocytes may contribute to disease development. Environmental factors, such as exposure to certain chemicals or prolonged skin irritation, are suspected but not conclusively proven. It is not contagious and cannot be transmitted between individuals.

Key Symptoms: Persistent patches, plaques, or tumors on the skin that may be itchy or scaly. Skin lesions that do not heal or improve over time. In advanced stages, swelling or enlargement of lymph nodes, especially in the axilla and upper limbs. Distribution of skin changes often appears on the torso, limbs, or other areas affected by the disease. Potential symptoms such as unexplained fatigue, weight loss, or night sweats in progressive cases.

Diagnosis Path: Medical history review and physical examination focusing on skin lesions and lymph node enlargement. Skin biopsies to analyze skin tissue samples for characteristic malignant T-cells. Imaging tests like ultrasound, CT scans, or PET scans to assess the extent of lymph node involvement. Blood tests to evaluate overall health and detect abnormal lymphocytes. Lymph node biopsy may be performed if nodes are significantly enlarged to confirm cancer spread.

Treatment Protocols: Topical therapies such as corticosteroids, retinoids, or radiation to target skin lesions. Phototherapy, which uses ultraviolet light to reduce abnormal T-cells in the skin. Systemic treatments like chemotherapy, immunotherapy, or biologic agents in advanced cases. Targeted radiation therapy for affected lymph nodes and surrounding tissues. Clinical trials or innovative therapies may be considered for refractory or advanced disease. Careful monitoring of disease progression and side effects by an oncology specialist is essential.